Company Filing History:
Years Active: 2021
Title: Hyun-Tak Jin: Innovator in Cervical Cancer Treatment
Introduction
Hyun-Tak Jin is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of medical treatment, particularly in addressing cervical cancer caused by human papillomavirus (HPV) infection. His innovative approach aims to improve treatment methods for this serious health issue.
Latest Patents
Hyun-Tak Jin holds 1 patent related to his work. His patent, titled "Methods of treating cervical cancer," focuses on enhancing the treatment of cervical tumors associated with HPV infection. The invention provides methods for utilizing a polynucleotide encoding an E6/E7 fusion protein to improve treatment outcomes for patients suffering from this condition.
Career Highlights
Hyun-Tak Jin is currently associated with Genexine, Inc., a company dedicated to developing innovative biopharmaceuticals. His work at Genexine reflects his commitment to advancing medical science and improving patient care through innovative treatments.
Collaborations
Throughout his career, Hyun-Tak Jin has collaborated with esteemed colleagues, including Hye Seong Lim and You Suk Suh. These collaborations have contributed to the development of effective treatment methods and have fostered a spirit of innovation within the field.
Conclusion
Hyun-Tak Jin's contributions to cervical cancer treatment exemplify the impact of innovation in medicine. His dedication to improving patient outcomes through his patented methods highlights the importance of research and collaboration in the fight against cancer.